查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1694821

2025年产前与新生儿基因检测全球市场报告

Prenatal And Newborn Genetic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年产前和新生儿基因检测市场将快速成长。到 2029 年，这一数字将成长至 120.4 亿美元，复合年增长率为 12.1%。预测期内的增长可归因于基因检测小组的扩大、人们对孕产妇健康认识的不断提高、产前和新生儿筛检指南、对罕见疾病的日益关注、伦理和监管考虑等。预测期内的主要趋势包括非侵入性产前检测 (NIPT)、基因组定序(WGS) 和全EXOME定序、人工智慧 (AI) 的整合、胚胎着床前基因检测 (PGT) 和直接面向消费者的基因检测。

政府对产前检测和新生儿基因筛检的倡议和支持预计将在短期内推动产前和新生儿基因检测市场的扩张。这些包括各级政府机构为解决具体问题或改善公民福祉而采取的具体行动、计划和政策。透过倡导和支持产前和新生儿基因检测项目，政府有助于在怀孕期间和出生后不久识别胎儿的基因异常和状况。例如，2022 年 6 月，澳洲政府承诺每年向新南威尔斯州 (NSW)新生儿筛检计画投入 130 万美元。这笔资金将用于免费检测严重联合免疫力缺乏(SCID) 和脊髓性肌肉萎缩症 (SMA)，并为该州所有新生儿提供基因筛检，每年可能挽救 10 万名患有这些遗传疾病的新生儿中的 13 人的生命。因此，政府加强产前和新生儿基因筛检的措施正在推动相关检测市场的成长。

预计遗传疾病盛行率的上升将推动未来产前和新生儿基因检测市场的成长。遗传疾病是由于个体 DNA 或遗传物质的异常或突变引起的疾病。产前和新生儿基因检测可以早期发现这些疾病，通常是在症状出现之前，使医疗保健提供者能够及时实施介入和治疗策略。例如，2024年5月，美国公共卫生机构疾病管制与预防中心（CDC）报告称，镰状细胞疾病（SCD）影响了美国约10万人。超过 90% 的受影响者是非西班牙裔黑人或非裔美国人，其中估计有 3%-9% 是西班牙裔或拉丁裔。因此，遗传疾病的日益普及正在推动产前和新生儿基因检测市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场－宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球产前和新生儿基因检测PESTEL分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球产前与新生儿基因检测市场：成长率分析
  • 全球产前与新生儿基因检测市场表现：规模与成长，2019-2024
  • 全球产前与新生儿基因检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球产前和新生儿基因检测总目标市场（TAM）

第六章市场区隔

  • 全球产前及新生儿基因检测市场（依产品类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 耗材
  • 装置
  • 全球产前及新生儿基因检测市场：销售额、收入及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 非侵入性产前检测
  • 慢性绒毛膜绒毛取样
  • 羊膜穿刺术
  • 母体血清筛检
  • 其他正在上映的电影
  • 全球产前和新生儿基因检测市场：按疾病、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 唐氏症
  • 苯酮尿症
  • 囊肿纤维化
  • 镰状细胞性贫血
  • 全球产前和新生儿基因检测市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 产科及专科诊所
  • 诊断中心
  • 全球产前及新生儿基因检测市场细分（按耗材类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 试剂和测定法
  • 样本采集套件
  • 检测套组
  • 全球产前和新生儿基因检测市场，仪器细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素链锁反应（PCR）设备
  • 序列器
  • 微阵列分析仪

第七章 区域和国家分析

  • 全球产前及新生儿基因检测市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球产前和新生儿基因检测市场：按国家、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 产前与新生儿基因检测市场：竞争格局
  • 产前与新生儿基因检测市场：公司简介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Danaher Corporation
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Quest Diagnostic Incorporated
  • Agilent Technologies Inc.
  • Grifols SA
  • Terumo Corporation
  • Illumina Inc.
  • PerkinElmer Genomics
  • Quidel Corporation
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Werfen SA
  • DiaSorin SpA
  • Nova Biomedical

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年产前与新生儿基因检测市场：提供新机会的国家
  • 2029年产前与新生儿基因检测市场：细分领域带来新机会
  • 2029年产前与新生儿基因检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r28798

Prenatal and newborn genetic testing encompasses medical procedures and screenings conducted during pregnancy and after birth to assess the genetic health and risk factors of both the developing fetus and the newborn baby. These tests are crucial for detecting and identifying genetic disorders, congenital conditions, or hereditary diseases that may impact the child's health or development.

The primary product types within the prenatal and newborn genetic testing domain include consumables and instruments. Instruments refer to specialized tools or devices designed for specific tasks or measurements, including various genetic analyzers used by healthcare professionals to conduct screenings and tests. Various screening methods include non-invasive prenatal testing, chronic villus sampling, amniocentesis, maternal serum screening, and others. The tests aim to identify diseases such as Down syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. These genetic testing products find application across diverse end-users, including hospitals, maternity and specialty clinics, and diagnostic centers.

The prenatal and newborn genetic testing market research report is one of a series of new reports from The Business Research Company that provides prenatal and newborn genetic testing market statistics, including prenatal and newborn genetic testing industry global market size, regional shares, competitors with a prenatal and newborn genetic testing market share, detailed prenatal and newborn genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal and newborn genetic testing industry. This prenatal and newborn genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal and newborn genetic testing market size has grown rapidly in recent years. It will grow from $6.68 billion in 2024 to $7.61 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to improved non-invasive prenatal testing, increased maternal age, government support and healthcare policies, patient demand for early detection.

The prenatal and newborn genetic testing market size is expected to see rapid growth in the next few years. It will grow to $12.04 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to expanded genetic test panels, increasing maternal health awareness, prenatal and newborn screening guidelines, rising focus on rare diseases, ethical and regulatory considerations. Major trends in the forecast period include non-invasive prenatal testing (NIPT), genome sequencing (WGS) and whole exome sequencing, integration of artificial intelligence (AI), preimplantation genetic testing (PGT), direct-to-consumer genetic testing.

Government initiatives and backing for prenatal testing and newborn genetic screening are anticipated to propel the expansion of the prenatal and newborn genetic testing markets in the foreseeable future. Such initiatives encompass specific actions, programs, or policies introduced by governmental bodies at various levels to address particular issues or promote the well-being of citizens. By advocating for and supporting prenatal and newborn genetic testing programs, governments contribute to the identification of genetic abnormalities or conditions in fetuses during pregnancy or shortly after birth. An illustration of this is seen in the Australian government's allocation of $1.3 million annually to the New South Wales (NSW) newborn screening program in June 2022. This funding facilitated free testing for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), providing genetic screening to all newborns in the state and potentially saving the lives of 13 infants with these genetic disorders among the 100,000 babies born yearly. Hence, government initiatives fortifying prenatal and newborn genetic screening drive the growth of the respective testing markets.

The rising incidence of genetic disorders is anticipated to drive growth in the prenatal and newborn genetic testing market in the future. Genetic disorders are medical conditions caused by abnormalities or mutations in an individual's DNA or genetic material. Prenatal and newborn genetic testing enables the early identification of these disorders, often before symptoms appear, allowing healthcare providers to implement timely interventions and treatment strategies. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported that sickle cell disease (SCD) affects approximately 100,000 individuals in the United States. Among those affected, over 90% are non-Hispanic Black or African American, while an estimated 3%-9% are Hispanic or Latino. Thus, the increasing prevalence of genetic disorders is propelling the growth of the prenatal and newborn genetic testing market.

Leading companies in the prenatal and newborn genetic testing sectors are concentrating on developing innovative screening tests, particularly noninvasive prenatal screening tests, to enhance accessibility and affordability while ensuring dependable services for customers. Noninvasive prenatal screening (NIPS) or noninvasive prenatal testing (NIPT) represents an advanced and secure genetic screening method conducted during pregnancy to evaluate the risk of specific fetal chromosomal abnormalities. An instance of this advancement is Juno Diagnostics Inc.'s introduction of Juno Hazel in November 2022. This noninvasive prenatal screening test identifies chromosomal anomalies and offers clinical content using a sample collection kit, eliminating the necessity for phlebotomy and enhancing accessibility. Additionally, the company intends to provide educational resources and personalized genetic counseling support by partnering with healthcare professionals and genetic counselors.

In February 2024, CooperSurgical Inc., a US-based medical equipment manufacturing company, formed a partnership with Fulgent Genetics to enhance its offerings in the prenatal and newborn genetic testing market. This collaboration aims to leverage Fulgent Genetics' expertise in advanced genetic testing solutions, particularly for families using the Cord Blood Registry. Fulgent Genetics Inc. specializes in providing a range of prenatal and newborn genetic testing services, which aligns with CooperSurgical's goals of expanding its portfolio and improving access to critical genetic testing options for expectant families.

Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal and newborn genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The prenatal and newborn genetic testing market consists of revenues earned by entities by providing services such as prenatal screening tests, prenatal diagnostic tests, carrier screening for genetic conditions, and newborn screening tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The prenatal and newborn genetic testing market also includes sales of electrophoresis equipment, genetic sequencing machines, and microarray analysis instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prenatal And Newborn Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal and newborn genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal and newborn genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prenatal and newborn genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Consumables; Instruments
  • 2) By Screening: Non-Invasive Prenatal Testing; Chronic Villus Sampling; Amniocentesis; Maternal Serum Screening; Other Screenings
  • 3) By Disease: Down Syndrome; Phenylketonuria; Cystic Fibrosis; Sickle Cell Anemia
  • 4) By End User: Hospital; Maternity And Specialty Clinics; Diagnostic Centers
  • Subsegments:
  • 1) By Consumables: Reagents And Assays; Sample Collection Kits; Test Kits
  • 2) By Instruments: Polymerase Chain Reaction (PCR) Machines; Sequencers; Microarray Analyzers
  • Companies Mentioned: F. Hoffmann-La Roche AG; Novartis AG; Sanofi S.A.; Thermo Fisher Scientific Inc.; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prenatal And Newborn Genetic Testing Market Characteristics

3. Prenatal And Newborn Genetic Testing Market Trends And Strategies

4. Prenatal And Newborn Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Prenatal And Newborn Genetic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Prenatal And Newborn Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Prenatal And Newborn Genetic Testing Market Growth Rate Analysis
  • 5.4. Global Prenatal And Newborn Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Prenatal And Newborn Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Prenatal And Newborn Genetic Testing Total Addressable Market (TAM)

6. Prenatal And Newborn Genetic Testing Market Segmentation

  • 6.1. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Instruments
  • 6.2. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Invasive Prenatal Testing
  • Chronic Villus Sampling
  • Amniocentesis
  • Maternal Serum Screening
  • Other Screenings
  • 6.3. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Down Syndrome
  • Phenylketonuria
  • Cystic Fibrosis
  • Sickle Cell Anemia
  • 6.4. Global Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Maternity And Specialty Clinics
  • Diagnostic Centers
  • 6.5. Global Prenatal And Newborn Genetic Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Assays
  • Sample Collection Kits
  • Test Kits
  • 6.6. Global Prenatal And Newborn Genetic Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR) Machines
  • Sequencers
  • Microarray Analyzers

7. Prenatal And Newborn Genetic Testing Market Regional And Country Analysis

  • 7.1. Global Prenatal And Newborn Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Prenatal And Newborn Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prenatal And Newborn Genetic Testing Market

  • 8.1. Asia-Pacific Prenatal And Newborn Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prenatal And Newborn Genetic Testing Market

  • 9.1. China Prenatal And Newborn Genetic Testing Market Overview
  • 9.2. China Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prenatal And Newborn Genetic Testing Market

  • 10.1. India Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prenatal And Newborn Genetic Testing Market

  • 11.1. Japan Prenatal And Newborn Genetic Testing Market Overview
  • 11.2. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prenatal And Newborn Genetic Testing Market

  • 12.1. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prenatal And Newborn Genetic Testing Market

  • 13.1. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prenatal And Newborn Genetic Testing Market

  • 14.1. South Korea Prenatal And Newborn Genetic Testing Market Overview
  • 14.2. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prenatal And Newborn Genetic Testing Market

  • 15.1. Western Europe Prenatal And Newborn Genetic Testing Market Overview
  • 15.2. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prenatal And Newborn Genetic Testing Market

  • 16.1. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prenatal And Newborn Genetic Testing Market

  • 17.1. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prenatal And Newborn Genetic Testing Market

  • 18.1. France Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prenatal And Newborn Genetic Testing Market

  • 19.1. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prenatal And Newborn Genetic Testing Market

  • 20.1. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prenatal And Newborn Genetic Testing Market

  • 21.1. Eastern Europe Prenatal And Newborn Genetic Testing Market Overview
  • 21.2. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prenatal And Newborn Genetic Testing Market

  • 22.1. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prenatal And Newborn Genetic Testing Market

  • 23.1. North America Prenatal And Newborn Genetic Testing Market Overview
  • 23.2. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prenatal And Newborn Genetic Testing Market

  • 24.1. USA Prenatal And Newborn Genetic Testing Market Overview
  • 24.2. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prenatal And Newborn Genetic Testing Market

  • 25.1. Canada Prenatal And Newborn Genetic Testing Market Overview
  • 25.2. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prenatal And Newborn Genetic Testing Market

  • 26.1. South America Prenatal And Newborn Genetic Testing Market Overview
  • 26.2. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prenatal And Newborn Genetic Testing Market

  • 27.1. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prenatal And Newborn Genetic Testing Market

  • 28.1. Middle East Prenatal And Newborn Genetic Testing Market Overview
  • 28.2. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prenatal And Newborn Genetic Testing Market

  • 29.1. Africa Prenatal And Newborn Genetic Testing Market Overview
  • 29.2. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prenatal And Newborn Genetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Prenatal And Newborn Genetic Testing Market Competitive Landscape
  • 30.2. Prenatal And Newborn Genetic Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Prenatal And Newborn Genetic Testing Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. Siemens Healthineers AG
  • 31.3. Becton, Dickinson and Company
  • 31.4. Quest Diagnostic Incorporated
  • 31.5. Agilent Technologies Inc.
  • 31.6. Grifols S.A.
  • 31.7. Terumo Corporation
  • 31.8. Illumina Inc.
  • 31.9. PerkinElmer Genomics
  • 31.10. Quidel Corporation
  • 31.11. Bio-Rad Laboratories Inc.
  • 31.12. Qiagen NV
  • 31.13. Werfen S.A.
  • 31.14. DiaSorin S.p.A
  • 31.15. Nova Biomedical

32. Global Prenatal And Newborn Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prenatal And Newborn Genetic Testing Market

34. Recent Developments In The Prenatal And Newborn Genetic Testing Market

35. Prenatal And Newborn Genetic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Prenatal And Newborn Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Prenatal And Newborn Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Prenatal And Newborn Genetic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer